Latanoprost Completed Phase 4 Trials for Glaucoma / Ocular Hypertension Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT00329095An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance